ACADVL anticorps (N-Term)
Aperçu rapide pour ACADVL anticorps (N-Term) (ABIN630886)
Antigène
Voir toutes ACADVL AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- ACADVL antibody was raised against the N terminal of ACADVL
-
Purification
- Affinity purified
-
Immunogène
- ACADVL antibody was raised using the N terminal of ACADVL corresponding to a region with amino acids RPYAGGAAQESKSFAVGMFKGQLTTDQVFPYPSVLNEEQTQFLKELVEPV
-
-
-
-
Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
ACADVL Blocking Peptide, (ABIN5611880), is also available for use as a blocking control in assays to test for specificity of this ACADVL antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of ACADVL antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- ACADVL (Acyl-CoA Dehydrogenase, Very Long Chain (ACADVL))
-
Autre désignation
- ACADVL
-
Sujet
- ACADVL is targeted to the inner mitochondrial membrane where it catalyzes the first step of the mitochondrial fatty acid beta-oxidation pathway. This acyl-Coenzyme A dehydrogenase is specific to long-chain and very-long-chain fatty acids. A deficiency in ACADVL protein reduces myocardial fatty acid beta-oxidation and is associated with cardiomyopathy.
-
Poids moléculaire
- 64 kDa (MW of target protein)
-
Pathways
- ER-Nucleus Signaling, Monocarboxylic Acid Catabolic Process
Antigène
-